| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00408-017-9987-3 |
| P698 | PubMed publication ID | 28238110 |
| P2093 | author name string | Onofrio Resta | |
| Pierluigi Carratu | |||
| Silvano Dragonieri | |||
| Giorgio Pennazza | |||
| P2860 | cites work | Bacteria classification using Cyranose 320 electronic nose | Q24798877 |
| Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study | Q24813038 | ||
| Statistical strategies for avoiding false discoveries in metabolomics and related experiments | Q27887473 | ||
| An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls | Q28248282 | ||
| Electronic nose: current status and future trends | Q28265278 | ||
| A novel multigene family may encode odorant receptors: a molecular basis for odor recognition | Q28276183 | ||
| Analysis of discrimination mechanisms in the mammalian olfactory system using a model nose | Q28278790 | ||
| Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline | Q28385458 | ||
| Reproducibility and respiratory function correlates of exhaled breath fingerprint in chronic obstructive pulmonary disease | Q28484411 | ||
| Diagnosing viral and bacterial respiratory infections in acute COPD exacerbations by an electronic nose: a pilot study | Q29304642 | ||
| Exhaled Breath Profiling Enables Discrimination of Chronic Obstructive Pulmonary Disease and Asthma | Q29395286 | ||
| Advances in electronic-nose technologies developed for biomedical applications | Q30470504 | ||
| Exhaled breath profiling for diagnosing acute respiratory distress syndrome | Q33613793 | ||
| Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study | Q34503888 | ||
| Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. | Q34535012 | ||
| Exhaled breath analysis using electronic nose in cystic fibrosis and primary ciliary dyskinesia patients with chronic pulmonary infections | Q34776102 | ||
| Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer. | Q34901092 | ||
| Electronic nose breathprints are independent of acute changes in airway caliber in asthma | Q35593466 | ||
| Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations | Q35768180 | ||
| Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array | Q36225814 | ||
| Medical applications of electronic nose technology | Q36315084 | ||
| A breath test for malignant mesothelioma using an electronic nose | Q59442465 | ||
| A nanomaterial-based breath test for short-term follow-up after lung tumor resection | Q59645458 | ||
| Diagnosing lung cancer in exhaled breath using gold nanoparticles | Q59645539 | ||
| Follow up of lung transplant recipients using an electronic nose | Q60221596 | ||
| Exercise changes volatiles in exhaled breath assessed by an electronic nose | Q60221620 | ||
| Exhaled breath volatile alterations in pregnancy assessed with electronic nose | Q60221623 | ||
| Prediction of lung cancer using volatile biomarkers in breath | Q80376203 | ||
| In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling | Q83294726 | ||
| Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD | Q84434300 | ||
| External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease | Q84511817 | ||
| Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose | Q84869740 | ||
| A profile of volatile organic compounds in breath discriminates COPD patients from controls | Q84886369 | ||
| Breathomics as a diagnostic tool for pulmonary embolism | Q85066723 | ||
| The volatile metabolic fingerprint of ventilator-associated pneumonia | Q87420915 | ||
| Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis | Q36620870 | ||
| Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study. | Q36826800 | ||
| Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose | Q36858058 | ||
| Detection of lung cancer by sensor array analyses of exhaled breath | Q37282778 | ||
| Quantitative Analysis of Urine Vapor and Breath by Gas-Liquid Partition Chromatography | Q37488234 | ||
| Immunologic aspects of chronic obstructive pulmonary disease | Q37506948 | ||
| Breathomics in lung disease | Q38308267 | ||
| Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma | Q38376328 | ||
| Inflammatory Asthma Phenotype Discrimination Using an Electronic Nose Breath Analyzer | Q38396668 | ||
| Exhaled breath analysis by electronic nose in respiratory diseases | Q38470325 | ||
| Established methodological issues in electronic nose research: how far are we from using these instruments in clinical settings of breath analysis? | Q38521607 | ||
| Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study | Q38798809 | ||
| An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. | Q40039324 | ||
| Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis | Q40429531 | ||
| Electronic nose analysis of exhaled breath to diagnose ventilator-associated pneumonia. | Q40462055 | ||
| An investigation on electronic nose diagnosis of lung cancer. | Q43230481 | ||
| Quantitative breath analysis of volatile organic compounds of lung cancer patients | Q43465470 | ||
| Diagnosis of pneumonia with an electronic nose: correlation of vapor signature with chest computed tomography scan findings | Q43594842 | ||
| Effect of transportation and storage using sorbent tubes of exhaled breath samples on diagnostic accuracy of electronic nose analysis | Q44260469 | ||
| Exhaled molecular profiles in the assessment of cystic fibrosis and primary ciliary dyskinesia. | Q45261198 | ||
| A proof of concept for the detection and classification of pulmonary arterial hypertension through breath analysis with a sensor array | Q45352177 | ||
| Detection of obstructive sleep apnoea by an electronic nose | Q45828570 | ||
| An electronic nose discriminates exhaled breath of patients with untreated pulmonary sarcoidosis from controls | Q45868312 | ||
| A chemometric study on human breath mass spectra for biomarker identification in cystic fibrosis | Q46913655 | ||
| Mass spectrometric profile of exhaled breath--field study by PTR-MS. | Q47850419 | ||
| Electronic nose prediction of a clinical pneumonia score: biosensors and microbes | Q47874393 | ||
| An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea. | Q47979241 | ||
| Comorbidity modulates non invasive ventilation-induced changes in breath print of obstructive sleep apnea syndrome patients. | Q48022682 | ||
| Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose | Q48106013 | ||
| Exhaled biomarker pattern is altered in children with obstructive sleep apnoea syndrome | Q48172843 | ||
| Subphenotypes of mild-to-moderate COPD by factor and cluster analysis of pulmonary function, CT imaging and breathomics in a population-based survey | Q48624092 | ||
| Prototype of a breath-based analysis system for medication compliance monitoring. | Q50854116 | ||
| A Non-invasive detection of lung cancer combined virtual gas sensors array with imaging recognition technique. | Q51070471 | ||
| Predicting steroid responsiveness in patients with asthma using exhaled breath profiling. | Q51148703 | ||
| Volatile signature for the early diagnosis of lung cancer. | Q51531597 | ||
| Breath biomarkers for lung cancer detection and assessment of smoking related effects--confounding variables, influence of normalization and statistical algorithms. | Q51690378 | ||
| Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease. | Q51694207 | ||
| Identification of upper respiratory bacterial pathogens with the electronic nose. | Q51708561 | ||
| Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis. | Q51717884 | ||
| Detecting active pulmonary tuberculosis with a breath test using nanomaterial-based sensors. | Q51726269 | ||
| Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative | Q56880334 | ||
| An electronic nose in the discrimination of patients with asthma and controls | Q57788732 | ||
| Detection of Mycobacterium tuberculosis (TB) in vitro and in situ using an electronic nose in combination with a neural network system | Q58310183 | ||
| Recognition of anaerobic bacterial isolates in vitro using electronic nose technology | Q58310198 | ||
| P433 | issue | 2 | |
| P921 | main subject | electronic nose | Q550092 |
| P304 | page(s) | 157-165 | |
| P577 | publication date | 2017-02-25 | |
| P1433 | published in | Lung | Q15765075 |
| P1476 | title | Electronic Nose Technology in Respiratory Diseases | |
| P478 | volume | 195 |
| Q90231171 | A Sensor Platform for Athletes' Training Supervision: A Proof of Concept Study |
| Q89968168 | Amine-Functionalized ZIF-8 as a Fluorescent Probe for Breath Volatile Organic Compound Biomarker Detection of Lung Cancer Patients |
| Q47215088 | Cancer breath testing: a patent review |
| Q90224831 | Detecting recurrent head and neck cancer using electronic nose technology: A feasibility study |
| Q47602316 | Early identification of wound infection: understanding wound odour. |
| Q88730902 | Evolution of clinical and environmental health applications of exhaled breath research: Review of methods and instrumentation for gas-phase, condensate, and aerosols |
| Q92903457 | Human Breathomics Database |
| Q92854301 | Hybrid Analytical Platform Based on Field-Asymmetric Ion Mobility Spectrometry, Infrared Sensing, and Luminescence-Based Oxygen Sensing for Exhaled Breath Analysis |
| Q47134751 | Identifying volatile metabolite signatures for the diagnosis of bacterial respiratory tract infection using electronic nose technology: A pilot study. |
| Q36396166 | Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis |
| Q58753434 | The Electronic Nose's Emerging Role in Respiratory Medicine |
Search more.